Trademark value indicators: Evidence from the trademark protection lifecycle in the U.S. pharmaceutical industry

Research output: Contribution to journalArticlepeer-review

Abstract

This work identifies and studies the determinants of trademark value. In particular, it focuses on trademark characteristics that are related to the underlying brand and on legally stipulated characteristics. To reveal the value implications of the identified trademark characteristics, it follows the idea that more valuable trademarks tend to be protected for a longer period than less valuable trademarks, provided that the benefits of this protection exceed its costs. Thus, those characteristics that have a positive association with the duration of trademark protection should indicate more valuable trademarks. The empirical analysis relies on studying trademark activities in the U.S. pharmaceutical industry, largely owing to its heavy reliance on product differentiation to compete in the market. The results suggest that trademark characteristics are an important predictor of trademark value. At the same time, the value interpretation of some characteristics depends on the stage of the trademark protection lifecycle (that is, registration, maintenance, or renewal) under consideration.
Original languageEnglish
Article number103929
JournalResearch Policy
Volume49
Issue number4
Early online date31 Jan 2020
DOIs
Publication statusPublished - 1 May 2020

Keywords

  • Pharmaceutical industry
  • Trademark lifecycle
  • Trademarks
  • Value indicators

Research Beacons, Institutes and Platforms

  • Manchester Institute of Innovation Research

Fingerprint

Dive into the research topics of 'Trademark value indicators: Evidence from the trademark protection lifecycle in the U.S. pharmaceutical industry'. Together they form a unique fingerprint.

Cite this